Fabian Finkelmeier

30PUBLICATIONS
133CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Organisational, interpersonal and intercultural communicationMicrofluidics and nanofluidicsBacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.

Mara Persano, Margherita Rimini, Francesca Salani

|Dec 28, 2024
Expression of claudin-18.2 in cholangiocarcinoma: a comprehensive immunohistochemical analysis from a German tertiary centre.

Maximilian N Kinzler, Steffen Gretser, Falko Schulze

|Nov 04, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Oct 25, 2024
Digital Translation Platform (Translatly) to Overcome Communication Barriers in Clinical Care: Pilot Study.

Victor Olsavszky, Mutaz Bazari, Taieb Ben Dai

|Sep 23, 2024
A New Drying Method of Thermolabile Flexible Endoscope Channels by Laminar and Turbulent Airflow: A Prospective, Randomized-Controlled, Single-Center, Proof-of-Concept Trial.

Florian A Michael, Michael Jung, Mike Reimers

|Sep 20, 2024
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort.

Katharina Mitzlaff, Martha M Kirstein, Christian Müller

Pageof 5

Frequent Collaborators

6 joint publications

Maximilian N Kinzler

5 joint publications

Bernhard Scheiner

5 joint publications

Marino Venerito

5 joint publications

Stefan Zeuzem